Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease which affects 3 million people worldwide.

Researchers developed a saliva based SERS platform that detects epilepsy, Parkinson's disease, and schizophrenia by analyzing protein structural changes with up to 98% accuracy.

One patient is currently undergoing treatment at Bharati Hospital, while the other, who was admitted to Deenanath Mangeshkar ...

Introduction Onchocerciasis, commonly known as river blindness, is a parasitic disease caused by Onchocerca volvulus affecting millions predominantly in sub-Saharan Africa. Robust epidemiological ...

Explore how proteomics in biomarker discovery accelerates diagnostic assay development and improves clinical validation.

Explore how proteomics enables personalized medicine by improving patient stratification, treatment response, and diagnostics ...

Introduction Burnout among healthcare professionals remains a critical public health issue linked to impaired cognition, emotional exhaustion and diminished clinical performance. Structured breathing ...

A test measuring proteins in spinal fluid may help support the diagnosis of MS, especially in patients whose disease is harder to diagnose.

Cerebrospinal fluid (CSF)-based molecular tests can reliably distinguish multiple sclerosis (MS) from other neurological conditions, according to a new study that analyzed cryopreserved CSF samples ...

Pathanamthitta , The SIT on Friday continued its sample collection for scientific analysis at the Sabarimala temple as part of the probe into the alleged loss of gold from artefacts at the hill shrine ...

An international research team, with significant involvement from the Medical University of Vienna, has developed a new AI-based analysis method that can accurately classify brain tumors using genetic ...